| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.62 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |